Metropolis Healthcare Ltd

At Metropolis Labs, we are committed to bringing new testing technologies that will assist doctors in making better clinical decisions and treatments, thereby enhancing the quality of patient care. In this direction, we are pleased to announce the #NextGenHLA Typing Test, which is powered by the complex molecular technology #nextgenerationsequencing (NGS). Metropolis' NextGen HLA Typing is a molecular test, which is performed for Bone Marrow Transplantation, also known as Hematopoietic Stem Cell Transplant (HSCT) & in Solid organ transplants such as Kidney transplants. This test aids in the identification of a suitable donor for bone marrow, cord blood, or organ transplant by analysing the Human Leukocyte Antigen (HLA) genes that a person has inherited from the parents. We believe that this test will help doctors find the right donors for their patients, resulting in successful transplants and higher survival rates. Metropolis Healthcare has established a centre of excellence for all transplant-related diagnostic services over the years, including the most comprehensive array of diagnostic tools, reports with more accurate interpretation, expert laboratory professionals, and subject matter specialists, making Metropolis a one-stop solution for all the transplant-related diagnostic needs. #MetropolisLab #Healthcare #DiagnosticLeader #Innovation #MetropolisScientificExpert #MolecularGenomicshttps://indiamedtoday.com/metropolis-launches-nextgen-hla-test-for-hsct-solid-organ-transplantation/ #NextGenHLA #nextgenerationsequencing #MetropolisLab #Healthcare #DiagnosticLeader #Innovation #MetropolisScientificExpert #MolecularGenomics

Check out this article in @ETHealth World authored by our #MetropolisScientificExpert Dr. Niranjan Patil, who explains how Whole Genome Sequencing by NGS Technology can aid in the diagnosis and management of drug-resistant tuberculosis. Dr. Niranjan Patil is the HOD and Scientific Business Head, Clinical Microbiology and Molecular Biology at Metropolis Healthcare's Global Reference Laboratory in Mumbai. #MetropolisHealthcare #LeadersinDiagnostics #Virology #innovationen #ScientificExpertise #MolecularGenomics #NextGenerationSequencinghttps://health.economictimes.indiatimes.com/news/diagnostics/current-role-of-application-of-whole-genome-sequencing-by-ngs-technology-in-drug-resistant-tb-diagnosis-and-management/98965752#:~:text=Whole%20genome%20sequencing%20by%20NGS%20has%20tremendous%20potential%20for%20quickly,the%20WGS%20by%20NGS%20methodology #MetropolisScientificExpert #MetropolisHealthcare #LeadersinDiagnostics #Virology #innovationen #ScientificExpertise #MolecularGenomics #NextGenerationSequencing

"The complexities of clinical presentations and the wide range of diagnostic tests available highlight the role of artificial intelligence (AI) and machine learning (ML) tools in supporting the National Tuberculosis Elimination Programme. It is critical to choose the right test/s for the prevailing clinical situation and to interpret the test results correctly," says Dr. Rohini Kelkar to ETHealthWorld. Check out this in-depth & insightful piece in which Dr. Rohini joins other scientific experts to share how digital technologies have been critical in enabling prompt and accurate tuberculosis diagnosis. #MetropolisScientificExpert Dr. Rohini Kelkar is the Senior Consultant, Infectious Diseases, Clinical Microbiology and Molecular Microbiology at Metropolis Healthcare Limited. At Metropolis, we all understand that underdiagnosis and multi-drug resistance are two aspects of Tuberculosis that require timely, accurate, and accessible diagnostic support. For more than a decade, Metropolis has provided the most comprehensive range of Tuberculosis tests, all of which are approved and recommended by WHO. The company has a dedicated Infectious Disease Division #Microxpert that has been assisting patients and clinicians from diagnosis to treatment by providing access to accurate lab results and WHO/NTEP approved advisory services via a novel model developed by Metropolis Healthcare's Innovation Cell. Metropolis has collaborated and worked with Central and State Government departments, Public Health departments, and Municipal Corporations across the country. Metropolis believes that its efforts in a variety of ways will help to strengthen the government's efforts to meet the TB elimination goals by 2025. Through CME Programs, national and international conferences, and information sharing, the company has been working to raise awareness among the medical community and laboratory practitioners about the latest trends and advancements in TB diagnosis. Furthermore, under the "Pradhan Mantri TB Mukt Abhiyan" initiative, the company has adopted 650 TB patients in Mumbai and has been providing nutritional support to them. #MetropolisHealthcare #LeadersinDiagnostics #Virology #Innovation #ScientificExpertise #CaringforCommunities #CorporateSocialresponsibility #TBEliminationProgramme #CSR #ESG #Sustainability #CreatingImpact #MetropolisbeyondDiagnostics #MolecularGenomics #NextGenerationSequencing https://health.economictimes.indiatimes.com/news/diagnostics/eliminate-tb-by-2025-indias-pipe-dream/98976231 #MetropolisScientificExpert #Microxpert #MetropolisHealthcare #LeadersinDiagnostics #Virology #Innovation #ScientificExpertise #CaringforCommunities #CorporateSocialresponsibility #TBEliminationProgramme #CSR #ESG #Sustainability #CreatingImpact #MetropolisbeyondDiagnostics #MolecularGenomics #NextGenerationSequencing

Here's an authored article in The New Indian Express by Dr. Vishal Wadhwa, (Head - Scientific Affairs, Metropolis Labs) on how personalised/precision medicine approach play a pivotal role in tailoring clinical strategies based on genomic, behavioural and environmental background of individual patients. To read the online version of the article, click here: https://lnkd.in/dXB7VakQ#Metropolislabs #Hepatitis #infectiousdiseases #MolecularGenomics #MolecularDiagnosis #Healthcare #Clinicalstrategies #Infectiousexpert #Leadingdiagnosticplayer #Metropolislabs #Hepatitis #infectiousdiseases #MolecularGenomics #MolecularDiagnosis #Healthcare #Clinicalstrategies #Infectiousexpert #Leadingdiagnosticplayer

What are #HereditaryCancers? What are its symptoms? What type of regular tests one should consider for the diagnosis of Hereditary Cancers? Find about the same in the below episode of #HealthMeet of #LifeandMore Plus, in which our #MetropolisScientificExpert Dr Shaikhali Barodawala, (Head of the Department of Surgical Pathology and Integrated Oncopathology Division, GRL, Metropolis Healthcare) speaks on #HereditaryCancers in detail. #HereditaryBreastandOvarianCancer #HBOC #MolecularOncology #MolecularGenomics #Genetictesting #Cancer #Oncology #MetropolisLab #Healthcare #BRCA #NextGenBRCAhttps://www.youtube.com/watch?v=Nl0XEiX0Ntk #HereditaryCancers #HealthMeet #LifeandMore #MetropolisScientificExpert #HereditaryBreastandOvarianCancer #HBOC #MolecularOncology #MolecularGenomics #Genetictesting #Cancer #Oncology #MetropolisLab #Healthcare #BRCA #NextGenBRCA

In an exclusive interaction with #Onlymyhealth, our #MetropolisScientificExpert Dr. Kavita Munjal, Technical Operations Head – Madhya Pradesh speaks about the prevalence of Breast Cancer and the need for awareness that can help in early detection and treatment. #MetropolisHealthcare #Breastcancerawareness #BreastCancertesting #BreastCancerdiagnosis #Diagnostictesting #Scientificexcellence #BRCA #MolecularGenomics #Genomexpert #MolecularOncologyhttps://www.onlymyhealth.com/breast-cancer-raise-awareness-and-prevention-1661172660 #Onlymyhealth #MetropolisScientificExpert #MetropolisHealthcare #Breastcancerawareness #BreastCancertesting #BreastCancerdiagnosis #Diagnostictesting #Scientificexcellence #BRCA #MolecularGenomics #Genomexpert #MolecularOncology

Check out this insightful interview of Dr Kirti Chadha, Chief Scientific Officer, Metropolis Labs, as she speaks to Financial Express (India) on the significance of ‘Noninvasive prenatal testing (NIPT)’ which is done to determine the risk that the fetus will be born with certain genetic abnormalities. In this article, she highlights the importance of such tests, scope of #genomics in India, #geneticabnormalities, among others. #MolecularGenomics #MetropolisInnovationCell #NextGenNIPT #NextGenBRCA #MolecularOncology #Genomexpert #Gynecexpert #Oncomet #genomics #geneticabnormalities #MolecularGenomics #MetropolisInnovationCell #NextGenNIPT #NextGenBRCA #MolecularOncology #Genomexpert #Gynecexpert #Oncomet